Dongguan, China

Xianwu Fu


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xianwu Fu: Innovator in Pharmaceutical Development

Introduction

Xianwu Fu is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on Teixobactin analogues. His research focuses on developing compounds that can effectively combat Gram-positive bacteria.

Latest Patents

Xianwu Fu holds a patent for a Teixobactin analogue and its use in pharmaceuticals. This patent describes a pharmaceutical composition that includes a compound capable of inhibiting the growth and reproduction of Gram-positive bacteria. The compound is characterized by Formula (Ia) or its various forms, including stereoisomers, tautomers, N-oxides, solvates, metabolites, pharmaceutically acceptable salts, or prodrugs. This innovation represents a promising advancement in antibiotic development.

Career Highlights

Throughout his career, Xianwu Fu has demonstrated a strong commitment to pharmaceutical research and development. His work has led to the creation of effective solutions for bacterial infections, addressing a critical need in modern medicine. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.

Collaborations

Xianwu Fu has collaborated with esteemed colleagues such as Qingyun Ren and Zhimin Xiong. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Xianwu Fu's innovative work in pharmaceuticals, particularly with Teixobactin analogues, showcases his dedication to advancing medical science. His contributions are vital in the ongoing battle against bacterial infections, highlighting the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…